Loading…

Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy

The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) a...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in medicine 2017-07, Vol.4, p.102-102
Main Authors: Mukhi, Dhanunjay, Nishad, Rajkishor, Menon, Ram K, Pasupulati, Anil Kumar
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763
cites cdi_FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763
container_end_page 102
container_issue
container_start_page 102
container_title Frontiers in medicine
container_volume 4
creator Mukhi, Dhanunjay
Nishad, Rajkishor
Menon, Ram K
Pasupulati, Anil Kumar
description The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) accounts for ~20-40% of mortality in DM. Proteinuria, a hallmark of renal glomerular diseases, indicates injury to the glomerular filtration barrier (GFB). The GFB is composed of glomerular endothelium, basement membrane, and podocytes. Podocytes are terminally differentiated epithelial cells with limited ability to replicate. Podocyte shape and number are both critical for the integrity and function of the GFB. Podocytes are vulnerable to various noxious stimuli prevalent in a diabetic milieu that could provoke podocytes to undergo changes to their unique architecture and function. Effacement of podocyte foot process is a typical morphological alteration associated with proteinuria. The dedifferentiation of podocytes from epithelial-to-mesenchymal phenotype and consequential loss results in proteinuria. Poorly controlled type 1 DM is associated with elevated levels of circulating growth hormone (GH), which is implicated in the pathophysiology of various diabetic complications including DN. Recent studies demonstrate that functional GH receptors are expressed in podocytes and that GH may exert detrimental effects on the podocyte. In this review, we summarize recent advances that shed light on actions of GH on the podocyte that could play a role in the pathogenesis of DN.
doi_str_mv 10.3389/fmed.2017.00102
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1d0d5828a4754de2b267f9087ab75fe9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1d0d5828a4754de2b267f9087ab75fe9</doaj_id><sourcerecordid>1924590080</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763</originalsourceid><addsrcrecordid>eNpVkcFPHCEUh0nTphr13FvDsZddH8wwQA9NjLa6ibFN2ia9EQYe7piZYQqzNvvfl3XV6Any-PG9Bx8hHxgsq0rp0zCgX3JgcgnAgL8hh5zrZqGE-vP2xf6AnOR8ByVTcVGz6j054ErWiilxSH7exHvs6ZmbuzhmGgO9TPHfvKZXMQ1xRNqN9Ef00W1nzJ_papj6ztl9OMRELzrb4tw5eoPTOsXJzuvtMXkXbJ_x5HE9Ir-_ff11frW4_n65Oj-7Xrha6HmhKwi2AcVBah0cZ7WAVgeNHCXWSotQCYWCt42y4L32rfdtLZFpVqqyqY7Ias_10d6ZKXWDTVsTbWceCjHdGpvKbD0a5sELxZWtpag98pY3MmhQ0rZSBNSF9WXPmjZt-VaH45xs_wr6-mTs1uY23hshoAFZF8CnR0CKfzeYZzN02WHf2xHjJhumeXk1gIISPd1HXYo5JwzPbRiYnVmzM2t2Zs2D2XLj48vpnvNPHqv_Mkuf9A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1924590080</pqid></control><display><type>article</type><title>Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy</title><source>PubMed Central</source><creator>Mukhi, Dhanunjay ; Nishad, Rajkishor ; Menon, Ram K ; Pasupulati, Anil Kumar</creator><creatorcontrib>Mukhi, Dhanunjay ; Nishad, Rajkishor ; Menon, Ram K ; Pasupulati, Anil Kumar</creatorcontrib><description>The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) accounts for ~20-40% of mortality in DM. Proteinuria, a hallmark of renal glomerular diseases, indicates injury to the glomerular filtration barrier (GFB). The GFB is composed of glomerular endothelium, basement membrane, and podocytes. Podocytes are terminally differentiated epithelial cells with limited ability to replicate. Podocyte shape and number are both critical for the integrity and function of the GFB. Podocytes are vulnerable to various noxious stimuli prevalent in a diabetic milieu that could provoke podocytes to undergo changes to their unique architecture and function. Effacement of podocyte foot process is a typical morphological alteration associated with proteinuria. The dedifferentiation of podocytes from epithelial-to-mesenchymal phenotype and consequential loss results in proteinuria. Poorly controlled type 1 DM is associated with elevated levels of circulating growth hormone (GH), which is implicated in the pathophysiology of various diabetic complications including DN. Recent studies demonstrate that functional GH receptors are expressed in podocytes and that GH may exert detrimental effects on the podocyte. In this review, we summarize recent advances that shed light on actions of GH on the podocyte that could play a role in the pathogenesis of DN.</description><identifier>ISSN: 2296-858X</identifier><identifier>EISSN: 2296-858X</identifier><identifier>DOI: 10.3389/fmed.2017.00102</identifier><identifier>PMID: 28748185</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>dedifferentiation ; diabetic nephropathy ; growth hormone ; hypertrophy ; Medicine ; podocytes ; zinc finger E-box binding homeobox2</subject><ispartof>Frontiers in medicine, 2017-07, Vol.4, p.102-102</ispartof><rights>Copyright © 2017 Mukhi, Nishad, Menon and Pasupulati. 2017 Mukhi, Nishad, Menon and Pasupulati</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763</citedby><cites>FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506074/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506074/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28748185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mukhi, Dhanunjay</creatorcontrib><creatorcontrib>Nishad, Rajkishor</creatorcontrib><creatorcontrib>Menon, Ram K</creatorcontrib><creatorcontrib>Pasupulati, Anil Kumar</creatorcontrib><title>Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy</title><title>Frontiers in medicine</title><addtitle>Front Med (Lausanne)</addtitle><description>The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) accounts for ~20-40% of mortality in DM. Proteinuria, a hallmark of renal glomerular diseases, indicates injury to the glomerular filtration barrier (GFB). The GFB is composed of glomerular endothelium, basement membrane, and podocytes. Podocytes are terminally differentiated epithelial cells with limited ability to replicate. Podocyte shape and number are both critical for the integrity and function of the GFB. Podocytes are vulnerable to various noxious stimuli prevalent in a diabetic milieu that could provoke podocytes to undergo changes to their unique architecture and function. Effacement of podocyte foot process is a typical morphological alteration associated with proteinuria. The dedifferentiation of podocytes from epithelial-to-mesenchymal phenotype and consequential loss results in proteinuria. Poorly controlled type 1 DM is associated with elevated levels of circulating growth hormone (GH), which is implicated in the pathophysiology of various diabetic complications including DN. Recent studies demonstrate that functional GH receptors are expressed in podocytes and that GH may exert detrimental effects on the podocyte. In this review, we summarize recent advances that shed light on actions of GH on the podocyte that could play a role in the pathogenesis of DN.</description><subject>dedifferentiation</subject><subject>diabetic nephropathy</subject><subject>growth hormone</subject><subject>hypertrophy</subject><subject>Medicine</subject><subject>podocytes</subject><subject>zinc finger E-box binding homeobox2</subject><issn>2296-858X</issn><issn>2296-858X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkcFPHCEUh0nTphr13FvDsZddH8wwQA9NjLa6ibFN2ia9EQYe7piZYQqzNvvfl3XV6Any-PG9Bx8hHxgsq0rp0zCgX3JgcgnAgL8hh5zrZqGE-vP2xf6AnOR8ByVTcVGz6j054ErWiilxSH7exHvs6ZmbuzhmGgO9TPHfvKZXMQ1xRNqN9Ef00W1nzJ_papj6ztl9OMRELzrb4tw5eoPTOsXJzuvtMXkXbJ_x5HE9Ir-_ff11frW4_n65Oj-7Xrha6HmhKwi2AcVBah0cZ7WAVgeNHCXWSotQCYWCt42y4L32rfdtLZFpVqqyqY7Ias_10d6ZKXWDTVsTbWceCjHdGpvKbD0a5sELxZWtpag98pY3MmhQ0rZSBNSF9WXPmjZt-VaH45xs_wr6-mTs1uY23hshoAFZF8CnR0CKfzeYZzN02WHf2xHjJhumeXk1gIISPd1HXYo5JwzPbRiYnVmzM2t2Zs2D2XLj48vpnvNPHqv_Mkuf9A</recordid><startdate>20170712</startdate><enddate>20170712</enddate><creator>Mukhi, Dhanunjay</creator><creator>Nishad, Rajkishor</creator><creator>Menon, Ram K</creator><creator>Pasupulati, Anil Kumar</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170712</creationdate><title>Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy</title><author>Mukhi, Dhanunjay ; Nishad, Rajkishor ; Menon, Ram K ; Pasupulati, Anil Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>dedifferentiation</topic><topic>diabetic nephropathy</topic><topic>growth hormone</topic><topic>hypertrophy</topic><topic>Medicine</topic><topic>podocytes</topic><topic>zinc finger E-box binding homeobox2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mukhi, Dhanunjay</creatorcontrib><creatorcontrib>Nishad, Rajkishor</creatorcontrib><creatorcontrib>Menon, Ram K</creatorcontrib><creatorcontrib>Pasupulati, Anil Kumar</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mukhi, Dhanunjay</au><au>Nishad, Rajkishor</au><au>Menon, Ram K</au><au>Pasupulati, Anil Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy</atitle><jtitle>Frontiers in medicine</jtitle><addtitle>Front Med (Lausanne)</addtitle><date>2017-07-12</date><risdate>2017</risdate><volume>4</volume><spage>102</spage><epage>102</epage><pages>102-102</pages><issn>2296-858X</issn><eissn>2296-858X</eissn><abstract>The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) accounts for ~20-40% of mortality in DM. Proteinuria, a hallmark of renal glomerular diseases, indicates injury to the glomerular filtration barrier (GFB). The GFB is composed of glomerular endothelium, basement membrane, and podocytes. Podocytes are terminally differentiated epithelial cells with limited ability to replicate. Podocyte shape and number are both critical for the integrity and function of the GFB. Podocytes are vulnerable to various noxious stimuli prevalent in a diabetic milieu that could provoke podocytes to undergo changes to their unique architecture and function. Effacement of podocyte foot process is a typical morphological alteration associated with proteinuria. The dedifferentiation of podocytes from epithelial-to-mesenchymal phenotype and consequential loss results in proteinuria. Poorly controlled type 1 DM is associated with elevated levels of circulating growth hormone (GH), which is implicated in the pathophysiology of various diabetic complications including DN. Recent studies demonstrate that functional GH receptors are expressed in podocytes and that GH may exert detrimental effects on the podocyte. In this review, we summarize recent advances that shed light on actions of GH on the podocyte that could play a role in the pathogenesis of DN.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>28748185</pmid><doi>10.3389/fmed.2017.00102</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2296-858X
ispartof Frontiers in medicine, 2017-07, Vol.4, p.102-102
issn 2296-858X
2296-858X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1d0d5828a4754de2b267f9087ab75fe9
source PubMed Central
subjects dedifferentiation
diabetic nephropathy
growth hormone
hypertrophy
Medicine
podocytes
zinc finger E-box binding homeobox2
title Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A36%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Actions%20of%20Growth%20Hormone%20in%20Podocytes:%20Implications%20for%20Diabetic%20Nephropathy&rft.jtitle=Frontiers%20in%20medicine&rft.au=Mukhi,%20Dhanunjay&rft.date=2017-07-12&rft.volume=4&rft.spage=102&rft.epage=102&rft.pages=102-102&rft.issn=2296-858X&rft.eissn=2296-858X&rft_id=info:doi/10.3389/fmed.2017.00102&rft_dat=%3Cproquest_doaj_%3E1924590080%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1924590080&rft_id=info:pmid/28748185&rfr_iscdi=true